ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.420
+0.035 (0.80%)
Aug 25, 2025, 11:55 AM - Market open
ENDRA Life Sciences Market Cap
ENDRA Life Sciences has a market cap or net worth of $3.33 million as of August 25, 2025. Its market cap has decreased by -28.80% in one year.
Market Cap
3.33M
Enterprise Value
2.05M
1-Year Change
-28.80%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since June 30, 2017, ENDRA Life Sciences's market cap has decreased from $15.15M to $3.33M, a decrease of -78.04%. That is a compound annual growth rate of -16.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 3.30M | -1.79% |
| Dec 31, 2024 | 3.36M | -81.25% |
| Dec 29, 2023 | 17.92M | 39.49% |
| Dec 30, 2022 | 12.85M | -55.92% |
| Dec 31, 2021 | 29.15M | 15.68% |
| Dec 31, 2020 | 25.20M | 100.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |